Technology | May 10, 2012

CompuMed to Offer GE Healthcare's ECG Technology for New Telemedicine Platform

Collaboration Enhances CompuMed's ECG Data for Cardiologists With GE Healthcare's MAC 800 Technology

May 10, 2012 — CompuMed, Inc. announced it will offer GE Healthcare's compact ECG platform, the MAC 800, as part of a next-generation telemedicine enhanced electrocardiogram (ECG) system. CardioGram System 907 is the latest evolution of CardioGram technology and combines data communications and telemedicine services to allow clinicians the ability to instantly access cardiologists for immediate ECG over-reads and teleconsulting.

"Our new CardioGram System 907 puts the cardiologist inside the machine," said CompuMed CEO Maurizio Vecchione. "GE Healthcare's advanced algorithms, combined with our integrated telemedicine services, provides full-time access to cardiology specialists in clinical settings that do not traditionally have these clinical experts."

Vecchione added that this allows low-risk patients to be accurately evaluated, preventing frequent false positives that result in unnecessary, costly and high-risk patients transfers. The new system offers features designed to meet the needs of markets such as rural healthcare, mental health facilities, surgery centers, assisted living centers and correctional healthcare.

"The MAC 800 at the heart of the new CardioGram System represents further advancement of ECG technology. Leveraging innovations in clinical measurement and algorithm interpretation, the MAC 800 helps minimize the time spent over-reading ECGs and aids in delivering accurate results for sub-acute populations. A critical challenge in sub-acute clinical environments is the non-specialized nature of the clinical staff, which can result in poor quality ECGs," said Yuval Shaked, general manager of diagnostic cardiology, GE Healthcare.

To meet this challenge the MAC 800 incorporates GE Healthcare's Hookup Advisor, which monitors lead signal quality and is designed to rapidly and effectively review ECG waveforms. It searches the recording for signs and causes of artifact, or noise that comes from sources other than the heart, including muscle artifact, baseline wonder, power line interference and electrode noise. Additionally, the MAC 800 provides real-time feedback to the health practitioner with suggestions for improved lead quality.

Low-quality ECGs can present challenges to accurate interpretation by technicians and by computerized ECG interpretation. Failure to minimize and recognize artifact while recording and to identify it during interpretation may result in an incorrect diagnosis of arrhythmias and other cardiac abnormalities, which can lead to unnecessary or inaccurate interventions and treatment.

For more information: www.compumed.net

Related Content

OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. Bittium Faros Holter monitoring.

The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. 
 

News | ECG | January 22, 2020
January 22, 2020 – Bittium is exhibiting solutions for cardiology at...
Cardiologs
News | ECG | December 12, 2019
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI)
FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...